Experimental Evolution Studies in Φ6 Cystovirus.

bacteriophage coinfection cystovirus experimental evolution genetic exchange genetic robustness host range mutational effects thermostability Φ6

Journal

Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722

Informations de publication

Date de publication:
18 Jun 2024
Historique:
received: 27 04 2024
revised: 05 06 2024
accepted: 08 06 2024
medline: 27 6 2024
pubmed: 27 6 2024
entrez: 27 6 2024
Statut: epublish

Résumé

Experimental evolution studies, in which biological populations are evolved in a specific environment over time, can address questions about the nature of spontaneous mutations, responses to selection, and the origins and maintenance of novel traits. Here, we review more than 30 years of experimental evolution studies using the bacteriophage (phage) Φ6 cystovirus. Similar to many lab-studied bacteriophages, Φ6 has a high mutation rate, large population size, fast generation time, and can be genetically engineered or cryogenically frozen, which facilitates its rapid evolution in the laboratory and the subsequent characterization of the effects of its mutations. Moreover, its segmented RNA genome, outer membrane, and capacity for multiple phages to coinfect a single host cell make Φ6 a good non-pathogenic model for investigating the evolution of RNA viruses that infect humans. We describe experiments that used Φ6 to address the fitness effects of spontaneous mutations, the consequences of evolution in the presence of coinfection, the evolution of host ranges, and mechanisms and consequences of the evolution of thermostability. We highlight open areas of inquiry where further experimentation on Φ6 could inform predictions for pathogenic viruses.

Identifiants

pubmed: 38932268
pii: v16060977
doi: 10.3390/v16060977
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NIGMS NIH HHS
ID : R16GM146706
Pays : United States
Organisme : Division of Research and Innovation, San José State University
ID : 23-SRF-08-051

Auteurs

Sonia Singhal (S)

Department of Biological Sciences, San José State University, San José, CA 95192, USA.

Akiko K Balitactac (AK)

Department of Biological Sciences, San José State University, San José, CA 95192, USA.

Aruna G Nayagam (AG)

Department of Biological Sciences, San José State University, San José, CA 95192, USA.

Parnian Pour Bahrami (P)

Department of Biological Sciences, San José State University, San José, CA 95192, USA.

Sara Nayeem (S)

Department of Biological Sciences, San José State University, San José, CA 95192, USA.

Paul E Turner (PE)

Department of Ecology and Evolutionary Biology, Yale University, New Haven, CT 06511, USA.
Program in Microbiology, Yale School of Medicine, New Haven, CT 06520, USA.
Center for Phage Biology and Therapy, Yale University, New Haven, CT 06511, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH